Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3205 to 3209 of 3209 entries
Sorted by: Best Match Show Resources per page
Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis.

Frontiers in pharmacology

Zhuo C, Lin C, Zhou C, Gao X, Shao H, Fang T, Tian H, Ding L, Liu M.
PMID: 35002700
Front Pharmacol. 2021 Dec 24;12:759262. doi: 10.3389/fphar.2021.759262. eCollection 2021.

No abstract available.

Cite
Zhuo C, Lin C, Zhou C, et al. Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis. Front Pharmacol. 2021;12:759262doi: 10.3389/fphar.2021.759262.
Zhuo, C., Lin, C., Zhou, C., Gao, X., Shao, H., Fang, T., Tian, H., Ding, L., & Liu, M. (2021). Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis. Frontiers in pharmacology, 12759262. https://doi.org/10.3389/fphar.2021.759262
Zhuo, Chuanjun, et al. "Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis." Frontiers in pharmacology vol. 12 (2021): 759262. doi: https://doi.org/10.3389/fphar.2021.759262
Zhuo C, Lin C, Zhou C, Gao X, Shao H, Fang T, Tian H, Ding L, Liu M. Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis. Front Pharmacol. 2021 Dec 24;12:759262. doi: 10.3389/fphar.2021.759262. eCollection 2021. PMID: 35002700; PMCID: PMC8741261.
Copy Download .nbib Format: NLM
Green fabrication of Co and Co.

Open life sciences

Waris A, Din M, Ali A, Afridi S, Baset A, Khan AU, Ali M.
PMID: 33817294
Open Life Sci. 2021 Jan 20;16(1):14-30. doi: 10.1515/biol-2021-0003. eCollection 2021.

Nanotechnology is the fabrication, characterization, and potential application of various materials at the nanoscale. Over the past few decades, nanomaterials have attracted researchers from different fields because of their high surface-to-volume ratio and other unique and remarkable properties. Cobalt...

Cite
Waris A, Din M, Ali A, et al. Green fabrication of Co and Co. Open Life Sci. 2021;16(1):14-30doi: 10.1515/biol-2021-0003.
Waris, A., Din, M., Ali, A., Afridi, S., Baset, A., Khan, A. U., & Ali, M. (2021). Green fabrication of Co and Co. Open life sciences, 16(1), 14-30. https://doi.org/10.1515/biol-2021-0003
Waris, Abdul, et al. "Green fabrication of Co and Co." Open life sciences vol. 16,1 (2021): 14-30. doi: https://doi.org/10.1515/biol-2021-0003
Waris A, Din M, Ali A, Afridi S, Baset A, Khan AU, Ali M. Green fabrication of Co and Co. Open Life Sci. 2021 Jan 20;16(1):14-30. doi: 10.1515/biol-2021-0003. eCollection 2021. PMID: 33817294; PMCID: PMC7968533.
Copy Download .nbib Format: NLM
Betaine improves growth performance, liver health, antioxidant status, breast meat yield, and quality in broilers fed a mold-contaminated corn-based diet.

Animal nutrition (Zhongguo xu mu shou yi xue hui)

Wen C, Chen R, Chen Y, Ding L, Wang T, Zhou Y.
PMID: 34430720
Anim Nutr. 2021 Sep;7(3):661-666. doi: 10.1016/j.aninu.2020.11.014. Epub 2021 Apr 29.

Betaine has been demonstrated to improve growth performance and antioxidant status of animals under various stress conditions. However, there is no literature on the effects of betaine in animals exposed to mycotoxins, which are among the most prevalent contaminants...

Cite
Wen C, Chen R, Chen Y, et al. Betaine improves growth performance, liver health, antioxidant status, breast meat yield, and quality in broilers fed a mold-contaminated corn-based diet. Anim Nutr. 2021;7(3):661-666doi: 10.1016/j.aninu.2020.11.014.
Wen, C., Chen, R., Chen, Y., Ding, L., Wang, T., & Zhou, Y. (2021). Betaine improves growth performance, liver health, antioxidant status, breast meat yield, and quality in broilers fed a mold-contaminated corn-based diet. Animal nutrition (Zhongguo xu mu shou yi xue hui), 7(3), 661-666. https://doi.org/10.1016/j.aninu.2020.11.014
Wen, Chao, et al. "Betaine improves growth performance, liver health, antioxidant status, breast meat yield, and quality in broilers fed a mold-contaminated corn-based diet." Animal nutrition (Zhongguo xu mu shou yi xue hui) vol. 7,3 (2021): 661-666. doi: https://doi.org/10.1016/j.aninu.2020.11.014
Wen C, Chen R, Chen Y, Ding L, Wang T, Zhou Y. Betaine improves growth performance, liver health, antioxidant status, breast meat yield, and quality in broilers fed a mold-contaminated corn-based diet. Anim Nutr. 2021 Sep;7(3):661-666. doi: 10.1016/j.aninu.2020.11.014. Epub 2021 Apr 29. PMID: 34430720; PMCID: PMC8358445.
Copy Download .nbib Format: NLM
Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma.

Oncotarget

Schutt CR, Sun H, Pradhan JS, Saenger Y, Ley J, Adkins D, Ingham M, Ding L, Van Tine BA.
PMID: 33796222
Oncotarget. 2021 Mar 16;12(6):534-548. doi: 10.18632/oncotarget.27907. eCollection 2021 Mar 16.

Head and neck cell squamous-cell carcinomas (HNSCC) are a group of common cancers typically associated with tobacco use and human papilloma virus infection. Up to half of all cases will suffer a recurrence after primary treatment. As such, new...

Cite
Schutt CR, Sun H, Pradhan JS, et al. Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. Oncotarget. 2021;12(6):534-548doi: 10.18632/oncotarget.27907.
Schutt, C. R., Sun, H., Pradhan, J. S., Saenger, Y., Ley, J., Adkins, D., Ingham, M., Ding, L., & Van Tine, B. A. (2021). Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. Oncotarget, 12(6), 534-548. https://doi.org/10.18632/oncotarget.27907
Schutt, Charles R, et al. "Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma." Oncotarget vol. 12,6 (2021): 534-548. doi: https://doi.org/10.18632/oncotarget.27907
Schutt CR, Sun H, Pradhan JS, Saenger Y, Ley J, Adkins D, Ingham M, Ding L, Van Tine BA. Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. Oncotarget. 2021 Mar 16;12(6):534-548. doi: 10.18632/oncotarget.27907. eCollection 2021 Mar 16. PMID: 33796222; PMCID: PMC7984826.
Copy Download .nbib Format: NLM
An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Ding L, Gao Q, Xu Z, Cai L, Chen S, Zhang X, Cao P, Chen G.
PMID: 34747156
Adv Sci (Weinh). 2022 Jan;9(2):e2103470. doi: 10.1002/advs.202103470. Epub 2021 Nov 07.

Oncolytic adenoviruses (Ads) have gained great attention in cancer therapy because they cause direct cytolytic infection and indirectly induce antitumor immunity. However, their efficacy is compromised by host antiviral immune response, poor tumor delivery, and the immunosuppressive tumor microenvironment...

Cite
Ding L, Gao Q, Xu Z, et al. An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer. Adv Sci (Weinh). 2021;9(2):e2103470doi: 10.1002/advs.202103470.
Ding, L., Gao, Q., Xu, Z., Cai, L., Chen, S., Zhang, X., Cao, P., & Chen, G. (2022). An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9(2), e2103470. https://doi.org/10.1002/advs.202103470
Ding, Li, et al. "An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 9,2 (2022): e2103470. doi: https://doi.org/10.1002/advs.202103470
Ding L, Gao Q, Xu Z, Cai L, Chen S, Zhang X, Cao P, Chen G. An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer. Adv Sci (Weinh). 2022 Jan;9(2):e2103470. doi: 10.1002/advs.202103470. Epub 2021 Nov 07. PMID: 34747156.
Copy Download .nbib Format: NLM
Showing 3205 to 3209 of 3209 entries